A lipomyelomeningocele is a closed, skin-covered spinal dysraphism in which a subcutaneous lipoma extends through a bony defect and intermingles with the neural placode, causing tethering of the spinal cord. The neural placode–lipoma interface lies outside the spinal canal because the dura is expanded into a sac-like configuration.

 

Q. How does lipomyelomeningocele differ from lipomyelocele?
 

The key difference lies in the position of the placode-lipoma interface:

In lipomyelomeningocele, the placode–lipoma junction lies outside the spinal canal, and the dura forms a meningocele-like expansion.
 

In lipomyelocele, the placode–lipoma interface remains within the spinal canal, and the dorsal defect is smaller with no significant dural expansion.
 

Both represent premature dysjunction with mesenchymal invasion, but lipomyelomeningocele is anatomically more externalized.

 

Q. What is the embryological basis of lipomyelomeningocele?
 

It arises from premature dysjunction i.e. the surface ectoderm separates from neural ectoderm too early during primary neurulation. This allows mesenchymal fat cells to invade the open neural plate, becoming incorporated into the forming spinal cord. As the cord closes, the fat remains attached, creating a tethering lipoma that extends out through a bony defect.

 

Q. How does a child with lipomyelomeningocele typically present?
 

Most children present with a skin-covered subcutaneous mass in the lumbosacral area, often with associated cutaneous markers such as a fatty lump, skin discoloration, or asymmetric gluteal cleft. Neurological deficits may be absent initially, but progressive tethered cord symptoms develop with growth, including gait disturbance, lower limb weakness, foot deformities, scoliosis, back pain, and urological deterioration such as neurogenic bladder. Dermal sinus tracts or infection may occur if associated epithelial elements are present.

 

Q. What imaging features suggest lipomyelomeningocele?
 

MRI is diagnostic. It shows:

A subcutaneous fat mass entering the spinal canal.

A thickened filum or lipoma attached to the neural placode.

The placode–lipoma interface located outside (in LMM) or inside (in LMC) the spinal canal.

Low-lying conus, usually below L2–L3.

Expanded dorsal dura in lipomyelomeningocele.
CT may show a posterior bony defect. MRI also evaluates associated tethered cord, syringomyelia, or split cord malformation.

 

Q. What are the indications for surgery in lipomyelomeningocele?
 

Surgery is indicated in:

Progressive neurological deficits

Urological deterioration on urodynamics

Orthopedic changes such as cavovarus foot or scoliosis

Documented tethered cord

Symptomatic or enlarging lipoma

Some surgeons also advocate prophylactic early surgery due to progressive tethering expected with growth, although timing varies by center.

 

Q. How will you surgically repair a lipomyelomeningocele?
 

I will position the child prone and mark the midline carefully. After sterile preparation, I will perform a midline skin incision over the subcutaneous lipoma and reflect the skin flaps to expose the fatty mass. I will dissect the lipoma circumferentially, identifying its deep extension into the spinal canal through the bony defect. Using the microscope, I will remove surrounding fat until I clearly identify the lipoma–placode interface.

 

I will perform a laminotomy around the defect as needed to expose the dura. I will open the dura longitudinally and tack it laterally. I will then identify the neural placode and inspect its attachment to the lipoma. I will use sharp microsurgical dissection to separate the lipoma from the neural tissue, preserving all functional nerve roots. I will follow the lipoma cranially and caudally until the tethering component is released. I will debulk the lipoma internal to the canal while avoiding traction on neural structures.

 

Once I free the placode from the lipoma, I will reconstruct the neural placode by approximating its medial edges. I will perform a generous dural expansion (duraplasty) using autologous or synthetic graft material to create a capacious dural sac that prevents retethering. I will achieve meticulous hemostasis and close the dura in a watertight manner. Finally, I will close muscle, fascia, subcutaneous tissue, and skin in layered fashion to provide robust coverage.

 

Q. What perioperative complications can occur during surgery for lipomyelomeningocele?
 

Perioperative complications include injury to the neural placode or exiting nerve roots during lipoma–placode dissection, leading to new motor or sensory deficits. Excessive bleeding from epidural veins or the lipoma can obscure the field. Dural tears outside the planned opening can make watertight closure difficult and predispose to CSF leak. Inadequate duraplasty or failure to create a capacious dural sac can leave the cord under tension and risk early retethering. Anesthetic issues in the prone position, hypothermia in small children, and hemodynamic instability can also complicate the procedure.

 

Q. What postoperative complications may follow lipomyelomeningocele repair?
 

Postoperative complications include CSF leak, pseudomeningocele, wound dehiscence, and wound infection or meningitis. New or worsened neurological deficits may appear if roots or cord have been injured or compressed. There is a significant long-term risk of retethering due to scarring at the placode–dural interface, which may present with recurrent pain, new weakness, foot deformity, or bladder deterioration. Progressive spinal deformity, particularly scoliosis or lordosis, can develop with growth. Urological complications may persist or worsen despite adequate detethering, requiring ongoing urology follow-up.

 

Q. How will you counsel the parents of a child with lipomyelomeningocele pre-operatively?
 

I will explain that lipomyelomeningocele is a congenital fatty mass attached to the spinal cord, causing tethering that can worsen with growth. I will clarify that the aim of surgery is to release the tethering, separate the lipoma from the neural tissue as safely as possible, and expand the dura to reduce the risk of future tethering. 

 

I will emphasize that surgery is intended primarily to stabilize or slow progression, not to guarantee neurological improvement, and that pre-existing deficits, especially bladder dysfunction, may not fully recover.

 

I will discuss perioperative risks including CSF leak, infection, and possible new weakness or sensory changes. I will stress the need for long-term follow-up with neurosurgery, urology, and orthopedics, warn about the possibility of retethering and further surgery in the future, and address their questions about walking potential, schooling, and continence in realistic but reassuring terms.

 

Q. What is the prognosis of lipomyelomeningocele?
 

Prognosis depends on preoperative neurological status. Early surgery offers better stabilization of motor and bladder function, but lifelong risk of retethering remains. Most children require long-term orthopedic and urological follow-up. Outcomes are generally better when surgery is performed before neurological decline.

 

Q. Are there any recent advancements in the management of lipomyelomeningocele?

 

Recent advancements focus on safer detethering and better long-term control of retethering. Intraoperative neurophysiological monitoring of motor and sensory pathways helps distinguish functional neural tissue from lipoma during dissection, reducing the risk of new deficits. High-resolution MRI and careful preoperative mapping improve understanding of the placode–lipoma interface. Modern duraplasty materials and techniques aim to create a generous, non-constricting dural sac to delay or reduce retethering. There is also increasing emphasis on early MRI-based screening, structured urodynamic follow-up, and multidisciplinary management protocols integrating neurosurgery, urology, and orthopedics to preserve function over time.